I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Machiels, J.-P.
254
results:
Search for persons
X
Format
Online (254)
Mediatypes
Articles (Online) (121)
Bookchapter (Online) (1)
OpenAccess-fulltext (132)
Languages
english (241)
dutch (2)
Sorted by: Relevance
Sorted by: Year
?
1
Health-Related Quality of Life (HRQoL) Data From KEYNOTE-41..:
Machiels, J.P.
;
TAO, Y.
;
Burtness, B.
...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e39-e40 , 2024
Link:
https://doi.org/10.1016/..
?
2
Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurren..:
Harrington, K.
;
Kim, H.R.
;
Salas, S.
...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e42 , 2024
Link:
https://doi.org/10.1016/..
?
3
Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone..:
Saba, N.F.
;
Harrington, K.
;
Licitra, L.
...
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e40-e41 , 2024
Link:
https://doi.org/10.1016/..
?
4
Pembrolizumab versus methotrexate, docetaxel, or cetuximab ..:
Harrington, K.J.
;
Cohen, E.E.W.
;
Soulières, D.
...
Oral Oncology. 147 (2023) - p. 106587 , 2023
Link:
https://doi.org/10.1016/..
?
5
Durvalumab with or without tremelimumab versus the EXTREME ..:
Psyrri, A.
;
Fayette, J.
;
Harrington, K.
...
Annals of Oncology. 34 (2023) 3 - p. 262-274 , 2023
Link:
https://doi.org/10.1016/..
?
6
Corrigendum to 'Salivary gland cancer: ESMO–European Refere..:
van Herpen, C.
;
Vander Poorten, V.
;
Skalova, A.
...
ESMO Open. 8 (2023) 5 - p. 101630 , 2023
Link:
https://doi.org/10.1016/..
?
7
Phase 2 LEAP-009: Lenvatinib (Lenva) With or Without Pembro..:
Harrington, K.
;
Cohen, E.
;
Siu, L.
...
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e43-e44 , 2022
Link:
https://doi.org/10.1016/..
?
8
A Phase 2/3, Randomized, Open-Label Study of Bempegaldesleu..:
Seiwert, T.Y.
;
Haddad, R.I.
;
Johnson, D.
...
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e36-e37 , 2022
Link:
https://doi.org/10.1016/..
?
9
Salivary gland cancer: ESMO–European Reference Network on R..:
van Herpen, C.
;
Vander Poorten, V.
;
Skalova, A.
...
ESMO Open. 7 (2022) 6 - p. 100602 , 2022
Link:
https://doi.org/10.1016/..
?
10
Isatuximab plus atezolizumab in patients with advanced soli..:
Simonelli, M.
;
Garralda, E.
;
Eskens, F.
...
ESMO Open. 7 (2022) 5 - p. 100562 , 2022
Link:
https://doi.org/10.1016/..
?
11
Reprint of "Squamous cell carcinoma of the oral cavity, lar..:
Machiels, J.-P.
;
René Leemans, C.
;
Golusinski, W.
...
Oral Oncology. 113 (2021) - p. 105042 , 2021
Link:
https://doi.org/10.1016/..
?
12
Safety of systemic anti-cancer treatment in oncology patien..:
van Marcke, C.
;
Honoré, N.
;
van der Elst, A.
...
BMC Cancer. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
13
Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practi..:
Keam, B.
;
Machiels, J.-P.
;
Kim, H.R.
...
ESMO Open. 6 (2021) 6 - p. 100309 , 2021
Link:
https://doi.org/10.1016/..
?
14
A 33-year-old man with jaundice, dyspnoea and fever:
Van Haren, M
;
Lenaerts, A
;
Paridaens, H
.
Clinics and Research in Hepatology and Gastroenterology. 43 (2019) 1 - p. 104-107 , 2019
Link:
https://doi.org/10.1016/..
?
15
Afatinib versus methotrexate in older patients with second-..:
Clement, P.M.
;
Gauler, T.
;
Machiels, J.P.
...
Annals of Oncology. 27 (2016) 8 - p. 1585-1593 , 2016
Link:
https://doi.org/10.1093/..
1-15